Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
Taysha Gene Therapies, Inc.
NASDAQ:TSHA
$5.7 USD
$0.32 (5.95%)
- Volume
- 4.58M
- Average Volume
- 3.11M
- Market Capitalization
- $1.43B
- P/E Ratio
- -14.89
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $7.30
- Year Low
- $2.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
| Date | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|
| 2026-08-11 | -0.11 | After Market Close | $- | $618.18K |
| 2026-05-06 | -0.10 | After Market Close | $- | $755.56K |
| 2026-03-19 | -0.11 | After Market Close | $5.48M | $2.24M |
| 2025-11-04 | -0.09 | After Market Close | $- | $1.89M |
| 2025-08-12 | -0.07 | After Market Close | $1.99M | $1.73M |
| 2025-05-15 | -0.08 | After Market Close | $2.3M | $1.08M |
| 2025-02-26 | -0.08 | After Market Close | $2.02M | $2.05M |
| 2024-11-13 | -0.08 | After Market Close | $1.79M | $2.05M |
| 2024-08-12 | -0.10 | After Market Close | $1.11M | $2.66M |
| 2024-05-14 | -0.11 | After Market Close | $3.41M | $2.56M |
| 2024-03-19 | -0.09 | After Market Close | $3.6M | $2.65M |
| 2023-11-14 | -0.13 | After Market Close | $4.75M | $2.65M |
| 2023-08-14 | -0.31 | After Market Close | $2.4M | $1.05M |
| 2023-05-11 | -0.35 | After Market Close | $4.71M | $70000 |
| 2023-03-28 | -0.41 | After Market Close | $2.5M | $8.18M |
| 2022-11-08 | -0.89 | After Market Close | $- | $- |
| 2022-08-11 | -1.05 | After Market Close | $- | $- |
| 2022-05-16 | -1.04 | After Market Close | $- | $- |
| 2022-03-31 | -1.21 | After Market Close | $- | $- |
| 2021-11-10 | -1.02 | After Market Close | $- | $- |
| 2021-08-16 | -0.81 | After Market Close | $- | $- |
| 2021-05-11 | -0.54 | After Market Close | $- | $- |
| 2021-03-03 | -0.37 | After Market Close | $- | $- |
| 2020-11-12 | -0.17 | After Market Close | $- | $- |
| 2020-09-25 | After Market Close | $- | $- | |
| 2020-06-30 | After Market Close | $- | $- | |
| 2019-12-31 | After Market Close | $- | $- |